SCHEMBL4038533

SCHEMBL4038533

Cc1cccc(Cl)c1Nc1nc2c(CCN)cc(N)nc2n2cncc12

nearest known ligand 0.61

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4036271 0.93 LCK (0.51) LCK
SCHEMBL4038532 0.84 LCK (0.65) LCK
SCHEMBL7981264 0.77 LCK (0.56) LCK
SCHEMBL4036269 0.76 LCK (0.55) LCK
SCHEMBL7969925 0.73 LCK (0.72) LCK
SCHEMBL4037406 0.73 LCK (0.59) LCK
SCHEMBL4039987 0.72 LCK (0.71) LCK
SCHEMBL7980457 0.72 LCK (0.82) LCK
SCHEMBL4036601 0.72 LCK (0.72) LCK
SCHEMBL4039227 0.72 LCK (0.47) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1066286-B1 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2009-04-29 EP claimed
EP-1066286-B1 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2009-04-29 EP disclosed